Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Many human diseases are characterized by the development of tissue hypoxia. Inadequate oxygenation can cause cellular dysfunction and death. Tissues use many strategies, including induction of angiogenesis and alterations in metabolism, to survive under hypoxic conditions. The heterodimeric transcription factor hypoxia-inducible factor (HIF) is a master regulator of genes that promote adaptation to hypoxia. HIF activity is linked to oxygen availability because members of the EGLN family hydroxylate HIFalpha subunits on specific prolyl residues when oxygen is present, which marks them for ubiquitination and proteasomal degradation. We created a mouse that ubiquitously expresses a bioluminescent reporter consisting of firefly luciferase fused to a region of HIF that is sufficient for oxygen-dependent degradation. Our validation studies suggest that this mouse will be useful for monitoring hypoxic tissues and evaluating therapeutic agents that stabilize HIF. One such agent, the HIF prolyl hydroxylase inhibitor FG-4383, was active in the liver and kidney after systemic administration as determined by bioluminescence imaging, transcription profiling, and production of erythropoietin, indicating that the HIF transcriptional program can be manipulated in vivo with orally active organic small molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“LPS-induced PHD inhibition was confirmed in DC derived from genetically engineered mice having the ODD domain fused to a luciferase gene (ODD-Luc; Safran et al., 2006).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Safran et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Shedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
Hypoxia of the Renal Medulla — Its Implications for Disease
Brezis, M., & Rosen, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321006 · Cited by 1,222
Role of the kidney in erythropoiesis
JACOBSON, L. O., GOLDWASSER, E., FRIED, W., & PLZAK, L. (1957) · Nature · doi:10.1038/179633a0 · Cited by 862
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citation
Research works printed but not linked: 2
- Zhong, Z., Arteel, G. E., Connor, H. D., Yin, M., Frankenberg, M. V., Stachlewitz, R. F., Raleigh, J. A., Mason, R. P. & Thurman, R. G. (1998) Am. J. Physiol. 275, F595–F604. [DOI] [PubMed] [Google Scholar]
- Heyman, S. N., Rosen, S. & Brezis, M. (1997) Blood Purif. 15, 232–242. [DOI] [PubMed] [Google Scholar]
Cited by
Kelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716
“Animal Studies Studies in HIF-luciferase reporter mice (Safran et al., 2006) were performed as described elsewhere (Campbell et al.”
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
Self-citationMaximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560
“In these mice, the oxygen-dependent degradation domain of HIF1α destabilizes luciferase, such that luciferase activity is increased only in conditions of HIF protein stabilization (such as in hypoxia) (34).”
BackgroundMethodInfluentialZheng, L., Kelly, C. J., & Colgan, S. P. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00191.2015 · Cited by 499
Campbell, E. L., Bruyninckx, W. J., Kelly, C. J., Glover, L. E., McNamee, E. N., Bowers, B. E., Bayless, A. J., Scully, M., Saeedi, B. J., Golden-Mason, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.020 · Cited by 476
“By utilizing HIF reporter ODD-luc mice (Safran et al., 2006) in combination with whole-tissue imaging, we quantified induction of colonic inflammation-associated hypoxia (Figures 3A and 3B).”
MethodHistone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Chakraborty, A. A., Laukka, T., Myllykoski, M., Ringel, A. E., Booker, M. A., Tolstorukov, M. Y., Meng, Y. J., Meier, S. R., Jennings, R. B., Creech, A. L., et al. (2019) · Science · doi:10.1126/science.aaw1026 · Cited by 432
Self-citationMonitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419
“…alleles have been reported in the literature (e.g., E2f-LUC [Uhrbom et al., 2004], ARF-GFP [Zindy et al., 2003], ODD-Luc [Goldman et al., 2011; Safran et al., 2006], and p21-p-luc [Ohtani et al., 2007]), but these models are not ideal as they are activated at late stages during…”
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
Optical Imaging: Current Applications and Future Directions
Luker, G. D., & Luker, K. E. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045799 · Cited by 404
“Kaelin and coworkers generated reporters for stability of p27, a negative regulator of the mammalian cell cycle, and Hif-1a, a transcription factor that is stabilized under hypoxic conditions (25,26).”
Cheon, D.-J., & Orsulic, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.154244 · Cited by 395
Erythropoietin after a century of research: younger than ever
Jelkmann, W. (2007) · European Journal of Haematology · doi:10.1111/j.1600-0609.2007.00818.x · Cited by 367
“a-Ketoglutarate antagonists, which inhibit the hydroxylation of HIF-a (HIF stabilisers), stimulate Epo production in the kidney and the liver (155).”
BackgroundInhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Bernhardt, W. M., Wiesener, M. S., Scigalla, P., Chou, J., Schmieder, R. E., Günzler, V., & Eckardt, K.-U. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010116 · Cited by 340
Self-citationKaelin, W. G. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092049 · Cited by 336
Self-citationHypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis
Konisti, S., Kiriakidis, S., & Paleolog, E. M. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.205 · Cited by 335
Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart
Kimura, W., Xiao, F., Canseco, D. C., Muralidhar, S., Thet, S., Zhang, H. M., Abderrahman, Y., Chen, R., Garcia, J. A., Shelton, J. M., et al. (2015) · Nature · doi:10.1038/nature14582 · Cited by 316
Eckle, T., Hartmann, K., Bonney, S., Reithel, S., Mittelbronn, M., Walker, L. A., Lowes, B. D., Han, J., Borchers, C. H., Buttrick, P. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2728 · Cited by 314
The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
Mimura, I., & Nangaku, M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.124 · Cited by 302
“A similar strategy using hypoxia-sensing transgenic mice and high-sensitivity in vivo fluorescence imaging”
MethodIncreased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289
Hypoxia as a key player in the AKI-to-CKD transition
Tanaka, S., Tanaka, T., & Nangaku, M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00425.2014 · Cited by 280
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 274
Bunn, H. F. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011619 · Cited by 234
“Several companies have developed inhibitors that induce Epo and erythropoiesis in mice (Safran et al. 2006; Yan et al. 2010) and in humans (Yan et al. 2010).”
BackgroundMicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
Toffanin, S., Hoshida, Y., Lachenmayer, A., Villanueva, A., Cabellos, L., Minguez, B., Savic, R., Ward, S. C., Thung, S., Chiang, D. Y., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.009 · Cited by 232
Frequently asked questions in hypoxia research
Wenger, R., Kurtcuoglu, V., Scholz, C., Marti, H., & Hoogewijs, D. (2015) · Hypoxia · doi:10.2147/hp.s92198 · Cited by 223
“At least the latter point has been circumvented by the generation of transgenic mice ubiquitously and constitutively expressing a luciferase reporter gene fused to the O 2 -dependent degradation domain of HIF1α.(24) Following the injection of luciferin, hypoxia-dependent bioluminescence can be imaged, which at least p…”
Oxygen Sensing and Homeostasis
Prabhakar, N. R., & Semenza, G. L. (2015) · Physiology · doi:10.1152/physiol.00022.2015 · Cited by 220
Holden, V. I., Breen, P., Houle, S., Dozois, C. M., & Bachman, M. A. (2016) · mBio · doi:10.1128/mbio.01397-16 · Cited by 205
“(ODD-Luc) (29), and conditional alveolar epithelial HIF-1 -deficient”
BackgroundLactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells
Sanmarco, L. M., Rone, J. M., Polonio, C. M., Fernandez Lahore, G., Giovannoni, F., Ferrara, K., Gutierrez-Vazquez, C., Li, N., Sokolovska, A., Plasencia, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06409-6 · Cited by 193
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394307-1.00003-5 · Cited by 190
“High-sensitivity in vivo fluorescence imaging showed low oxygen tension in the kidney of transgenic mice, even under normoxic conditions (Safran et al., 2006).”
BackgroundHypoxia in tissue repair and fibrosis
Darby, I. A., & Hewitson, T. D. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2461-3 · Cited by 188
Tumor models for efficacy determination
Teicher, B. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0391 · Cited by 186
“(49) developed a genetically engineered mouse that”
Seim, G. L., Britt, E. C., John, S. V., Yeo, F. J., Johnson, A. R., Eisenstein, R. S., Pagliarini, D. J., & Fan, J. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0083-2 · Cited by 178
Blood doping and its detection
Jelkmann, W., & Lundby, C. (2011) · Blood · doi:10.1182/blood-2011-02-303271 · Cited by 143
“α-Ketoglutarate competitors ("HIF stabilizers") are orally active compounds that stimulate Epo production and erythropoiesis.(63,64) A number of chemically different HIF stabilizers has been identified.”
BackgroundHIF in Kidney Disease and Development
Gunaratnam, L., & Bonventre, J. V. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070804 · Cited by 173
Hsieh, M. M., Linde, N. S., Wynter, A., Metzger, M., Wong, C., Langsetmo, I., Lin, A., Smith, R., Rodgers, G. P., Donahue, R. E., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073254 · Cited by 171
Paliege, A., Rosenberger, C., Bondke, A., Sciesielski, L., Shina, A., Heyman, S. N., Flippin, L. A., Arend, M., Klaus, S. J., & Bachmann, S. (2010) · Kidney International · doi:10.1038/ki.2009.460 · Cited by 170
Self-citationHIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
Bishop, T., & Ratcliffe, P. J. (2015) · Circulation Research · doi:10.1161/circresaha.117.305109 · Cited by 169
HIF1A Reduces Acute Lung Injury by Optimizing Carbohydrate Metabolism in the Alveolar Epithelium
Eckle, T., Brodsky, K., Bonney, M., Packard, T., Han, J., Borchers, C. H., Mariani, T. J., Kominsky, D. J., Mittelbronn, M., & Eltzschig, H. K. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001665 · Cited by 165
“In addition, we examined pulmonary HIF1A levels utilizing a previously characterized HIF reporter mouse model [63].”
MethodReactivation of hepatic EPO synthesis in mice after PHD loss
Minamishima, Y. A., & Kaelin, W. G. (2010) · Science · doi:10.1126/science.1192811 · Cited by 163
Self-citationLin, W., Cao, J., Liu, J., Beshiri, M. L., Fujiwara, Y., Francis, J., Cherniack, A. D., Geisen, C., Blair, L. P., Zou, M. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110104108 · Cited by 163
“RBP2 belongs to a superfamily of 2-oxoglutarate–dependent dioxygenases (18, 19), which can be inhibited with drug-like small molecules (20, 21).”
Self-citationSpeer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 155
“A fusion protein containing the oxygen-dependent degradation domain of HIF-1a (aa 530–652) fused to firefly luciferase under control of the cytomegalovirus promoter has been previously used as a reporter for HIF-1a stabilization in highthroughput screening for novel activators of the hypoxic response [78] and for in v…”
MethodMiller, I. C., Zamat, A. H., Sun, L.-K., Phuengkham, H., Harris, A. M., Gamboa, L., Yang, J., Murad, J. P., Priceman, S. J., & Kwong, G. A. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00781-2 · Cited by 163
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161
“It has also become clear that members of this family can be directly inhibited with drug-like small molecules that bind to their catalytic sites and interfere with 2-oxogluta- rate binding, iron binding, or both (Ivan et al. 2002; Mole et al. 2003; Schlemminger et al. 2003; Safran et al. 2006).”
Self-citationA feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo
Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R., & Kaelin, W. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-09 · Cited by 161
“6B) or by treatment with small molecules that inhibit all three PHD family members (44).”
BackgroundSelf-citationActivation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
Xie, C., Yagai, T., Luo, Y., Liang, X., Chen, T., Wang, Q., Sun, D., Zhao, J., Ramakrishnan, S. K., Sun, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4412 · Cited by 161
Angiogenesis and hypoxia in the kidney
Tanaka, T., & Nangaku, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.35 · Cited by 163
Tumor Models for Efficacy Determination
Teicher, B. A. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0391 · Cited by 155
Forristal, C. E., Winkler, I. G., Nowlan, B., Barbier, V., Walkinshaw, G., & Levesque, J.-P. (2013) · Blood · doi:10.1182/blood-2012-02-408419 · Cited by 135
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
“, with DFO) or iron supplementation can stimulate or inhibit the activity of these enzymes, respectively (263, 290, 297).”
BackgroundEGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
Olenchock, B. A., Moslehi, J. J., Baik, A. H., Davidson, S. M., Williams, J., Gibson, W. J., Chakraborty, A. A., Pierce, K. A., Miller, C. M., Hanse, E. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.006 · Cited by 150
“In Vivo Bioluminescence Imaging In vivo bioluminescence imaging was done as previously described (Safran et al., 2006).”
InfluentialSelf-citationControl of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
Zhang, Q., Gu, J., Li, L., Liu, J., Luo, B., Cheung, H.-W., Boehm, J. S., Ni, M., Geisen, C., Root, D. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.029 · Cited by 139
“These enzymes C can be inhibited with drug-like small molecules that compete with 2-oxoglutarate or interfere with iron utilization, both in vitro and in vivo (Bruegge et al., 2007; Mole et al., 2003; Ozer and Bruick, 2007; Safran et al., 2006).”
Self-citationKaruppagounder, S. S., Alim, I., Khim, S. J., Bourassa, M. W., Sleiman, S. F., John, R., Thinnes, C. C., Yeh, T.-L., Demetriades, M., Neitemeier, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6008 · Cited by 141
Real-Time Imaging of HIF-1α Stabilization and Degradation
Moroz, E., Carlin, S., Dyomina, K., Burke, S., Thaler, H. T., Blasberg, R., & Serganova, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005077 · Cited by 118
“reporter expression (BLI and immunoblot), reflecting the effect of ODDD deletion on the stability of the fusion protein [35].”
BackgroundThe human oxygen sensing machinery and its manipulation
Chowdhury, R., Hardy, A., & Schofield, C. J. (2008) · Chemical Society Reviews · doi:10.1039/b701676j · Cited by 109
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
Kaelin, W. G. (2017) · Europe PMC (PubMed Central) · Cited by 137
Self-citationZinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo
Nardinocchi, L., Pantisano, V., Puca, R., Porru, M., Aiello, A., Grasselli, A., Leonetti, C., Safran, M., Rechavi, G., Givol, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015048 · Cited by 129
“We found that a reporter consisting of the oxygen-dependent degradation domain of HIF1a (aa 530–652) fused to the N terminus of firefly luciferase (ODDluc) [25] was responsive to zinc treatment in vitro and in vivo.”
BackgroundMethodSelf-citationSiddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
“Using in vivo imaging system using animals expressing reporters coding for luminescent proteins such as luciferase will provide a better understanding of the effects of the pharmacological inhibitors of these enzymes in vivo [57].”
BackgroundRegulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells
Wenger, R. H., & Hoogewijs, D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00736.2009 · Cited by 117
“Protein hydroxylase inhibitors also stimulated Epo production in mouse and rhesus macaque models (49, 118).”
BackgroundHoppe, G., Yoon, S., Gopalan, B., Savage, A. R., Brown, R. D., Case, K. R., Vasanji, A., Chan, E. R., Silver, R. B., & Sears, J. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523005113 · Cited by 123
“Live imaging of luciferase activity was performed using Bruker Xtreme small-animal X-ray, a fluorescence bioluminescence imaging system (25) (SI Materials and Methods).”
MethodGruber, T., Pan, C., Contreras, R. E., Wiedemann, T., Morgan, D. A., Skowronski, A. A., Lefort, S., De Bernardis Murat, C., Le Thuc, O., Legutko, B., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.007 · Cited by 113
Novel Erythropoiesis-Stimulating Agents: A New Era in Anemia Management
Macdougall, I. C. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03840907 · Cited by 120
“The primary aim of the initial studies was to develop drugs for the treatment of fibrotic diseases (52,53); however, the 2-oxoglutarate analogues were found to stimulate erythropoiesis in vivo (54).”
BackgroundAttenuating myocardial ischemia by targeting A2B adenosine receptors
Eltzschig, H. K., Bonney, S. K., & Eckle, T. D. L. G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.005 · Cited by 122
Fan, L., Li, J., Yu, Z., Dang, X., & Wang, K. (2014) · BioMed Research International · doi:10.1155/2014/239356 · Cited by 119
“Many studies based on cells or animals have revealed that oxoglutarate analogues can produce beneficial biological results by stabilising HIFs [28–31].”
BackgroundDrug-induced regeneration in adult mice
Zhang, Y., Strehin, I., Bedelbaeva, K., Gourevitch, D., Clark, L., Leferovich, J., Messersmith, P. B., & Heber-Katz, E. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010228 · Cited by 102
Anemia and Cerebral Outcomes: Many Questions, Fewer Answers
Hare, G. M. T., Tsui, A. K. Y., McLaren, A. T., Ragoonanan, T. E., Yu, J. L., & Mazer, C. D. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318184cfe9 · Cited by 112
“The use of PHD inhibitors to stabilize HIF may provide another potential neuroprotective strategy.(178,179)”
MethodActivation of the Renin-Angiotensin System and Chronic Hypoxia of the Kidney
Nangaku, M., & Fujita, T. (2008) · Hypertension Research · doi:10.1291/hypres.31.175 · Cited by 113
“recently used a similar strategy to establish hypoxia-sensing transgenic mice (32).”
MethodThe Different Routes to Metastasis via Hypoxia-Regulated Programs
Nobre, A. R., Entenberg, D. R., Wang, Y., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.008 · Cited by 111
“Several reporter proteins were developed including GFP [80–82], YFP [83], and firefly luciferase [84,85]; albeit with some limitations.”
MethodSiegert, I., Schödel, J., Nairz, M., Schatz, V., Dettmer, K., Dick, C., Kalucka, J., Franke, K., Ehrenschwender, M., Schley, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.005 · Cited by 110
Epithelial HIF-1α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis
Masterson, J. C., Biette, K. A., Hammer, J. A., Nguyen, N. T., Capocelli, K. E., Saeedi, B. J., Harris, R. F., Fernando, S. D., Hosford, L., Kelly, C. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126744 · Cited by 105
“ODD-LUC mouse (52) esophageal tissues were sonicated and”
MethodRenal Hypoxia in CKD; Pathophysiology and Detecting Methods
Hirakawa, Y., Tanaka, T., & Nangaku, M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00099 · Cited by 105
“A similar approach was employed by Safran et al. who established a hypoxia-sensing mouse strain that expressed firefly luciferase fused to the HIF-1α protein (Safran et al., 2006).”
InfluentialMcClendon, J. D., Jansing, N. L., Redente, E. F., Gandjeva, A., Ito, Y., Colgan, S. P., Ahmad, A. M., Riches, D. W. H., Chapman, H. A., Mason, R. J., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.012 · Cited by 105
Smirnova, N. A., Haskew-Layton, R. E., Basso, M., Hushpulian, D. M., Payappilly, J. B., Speer, R. E., Ahn, Y.-H., Rakhman, I., Cole, P. A., Pinto, J. T., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.013 · Cited by 95
“The developed Neh2-luc reporter is perfectly suited for HTS purposes, for studying the mechanistic details of drug action, and by analogy with HIF ODD-luc system (Safran et al., 2006), we are confident that the reporter may be successfully used for in vivo imaging of Nrf2 activators in animals.”
BackgroundLu, X., Yan, C. H., Yuan, M., Wei, Y., Hu, G., & Kang, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3739 · Cited by 86
Capillary rarefaction from the kidney point of view
Afşar, B., Afşar, R. E., Dağel, T., Kaya, E., Erus, S., Ortíz, A., Covic, A. C., & Kanbay, M. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx133 · Cited by 102
“As a result, the cortex pO2 is between 30 and 50 mmHg, while in the medulla and medullary rays it is 10–20 mmHg, the lowest in the body [7, 8].”
BackgroundBeuck, S., Schänzer, W., & Thevis, M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.390 · Cited by 101
Miao, H., Chen, L., Hao, L., Zhang, X., Chen, Y., Ruan, Z., & Liang, H. (2015) · Scientific Reports · doi:10.1038/srep13092 · Cited by 94
Nonrenal regulation of EPO synthesis
Weidemann, A., & Johnson, R. S. (2009) · Kidney International · doi:10.1038/ki.2008.687 · Cited by 98
“Several of such inhibiting compounds are now available, and animal studies have established the proof of concept that endogenous hepatic EPO can be upregulated by pharmacological stabilization of HIF-a subunits in nephrectomized mice.(52) The first human trials using HIF-stabilizing compounds have been conducted in an…”
BackgroundMolecular imaging strategies for drug discovery and development
Gross, S., & Piwnica-Worms, D. R. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.06.028 · Cited by 95
HIF-Prolyl Hydroxylases in the Rat Kidney
Schödel, J., Klanke, B., Weidemann, A., Buchholz, B., Bernhardt, W. M., Bertog, M., Amann, K., Korbmacher, C., Wiesener, M. S., Warnecke, C., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080687 · Cited by 93
HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammation
Zampell, J. C., Yan, A., Avraham, T., Daluvoy, S., Weitman, E. S., & Mehrara, B. J. (2012) · The FASEB Journal · doi:10.1096/fj.11-195321 · Cited by 83
“To determine mechanisms regulating HIF-1 expression in the wound, tail operations were performed in ROSA26 ODD-Luc/ (ODD-Luc/ ) mice in which the luciferase reporter is fused to a HIF-1 gene residue subject to oxygen-dependent degradation, thereby enabling HIF-1 imaging in vivo (21).”
MethodHypoxia and fibrosis in chronic kidney disease: crossing at pericytes
Kawakami, T., Mimura, I., Shoji, K., Tanaka, T., & Nangaku, M. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.20 · Cited by 87
Gao, R. Y., Wang, M., Liu, Q., Feng, D., Wen, Y., Xia, Y., Colgan, S. P., Eltzschig, H. K., & Ju, C. (2020) · Hepatology · doi:10.1002/hep.30954 · Cited by 79
Control of Erythropoietin Gene Expression and its Use in Medicine
JELKMANN, W. E. B. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35010-6 · Cited by 82
Therapeutic Manipulation of the HIF Hydroxylases
Nagel, S., Talbot, N. P., Mecinović, J., Smith, T. G., Buchan, A. M., & Schofield, C. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2711 · Cited by 86
“In the mouse, oral or intravenous PHD inhibition inhibits renal HIF hydroxylase activity and increases EPO production (81, 166).”
Imaging and Oncologic Drug Development
El‐Deiry, W. S., Sigman, C. C., & Kelloff, G. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5623 · Cited by 82
Barrett, T. D., Palomino, H. L., Brondstetter, T. I., Kanelakis, K. C., Wu, X., Haug, P. V., Yan, W., Young, A., Hua, H., Hart, J. C., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070508 · Cited by 78
“the HIF-driven luciferase mouse model (Safran et al., 2006).”
Induction of long noncoding RNA MALAT1 in hypoxic mice
Wenger, R. H., Lelli, A., Nolan, K., Santambrogio, S., Marti, H. H., Hoogewijs, D., Frew, I. J., Goncalves, A. F., Schönenberger, M. J., & Guinot, A. (2015) · Hypoxia · doi:10.2147/hp.s90555 · Cited by 78
Smirnova, N. A., Rakhman, I., Moroz, N., Basso, M., Payappilly, J., Kazakov, S., Hernandez-Guzman, F., Gaisina, I. N., Kozikowski, A. P., Ratan, R. R., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.008 · Cited by 75
“Another limitation is the use of a 19-mer HIF peptide, whose affinity for the HIF PHDs is orders of magnitude lesser than the full-length protein.”
BackgroundMethodInfluentialComprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
Kamezaki, M., Kusaba, T., Komaki, K., Fushimura, Y., Watanabe, N., Ikeda, K., Kitani, T., Yamashita, N., Uehara, M., Kirita, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22229-5 · Cited by 73
Li, Y., Gong, Y., Ning, X., Ding, P., Liu, L., He, S., Gong, K., Zhang, C., Li, X., & Zhou, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0924-y · Cited by 76
Tsui, A. K. Y., Marsden, P. A., Mazer, C. D., Adamson, S. L., Henkelman, R. M., Ho, J. J. D., Wilson, D. F., Heximer, S. P., Connelly, K. A., Bolz, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114026108 · Cited by 75
“We then used hemizygous HIF-α(ODD)-luciferase mice to further define the molecular basis of the changes in HIF-α protein levels in anemia and hypoxia in vivo (29).”
Clinical imaging of hypoxia: Current status and future directions
Bonnitcha, P., Grieve, S. M., & Figtree, G. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.019 · Cited by 73
Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia
Selfridge, A. C., Cavadas, M. A. S., Scholz, C. C., Campbell, E. L., Welch, L. C., Lecuona, E., Colgan, S. P., Barrett, K. E., Sporn, P. H. S., Sznajder, J. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713941 · Cited by 67
“Experiment B was conducted at University of Colorado Denver, with 18- to 20-week old female ODD-Luc mice maintained on an Friend virus B background (26).”
MethodHouten, S. M., Volle, D. H., Cummins, C. L., Mangelsdorf, D. J., & Auwerx, J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0113 · Cited by 66
“Over the past few years, luciferase has been used for imaging the in vivo activity of transcription factors, such as nuclear factor- B (14–16) and hypoxia-inducible factor-1 (17), but also to score promoter activity (e.”
MethodBioluminescence Imaging Applications in Cancer: A Comprehensive Review
AlSawaftah, N., Farooq, A., Dhou, S., & Majdalawieh, A. F. (2020) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2995124 · Cited by 72
“A study conducted by Yu and colleagues used a pcDNA3-Luc vector [99], a FLuc reporter vector, optimized for mammalian expression [85].”
MethodMukherjee, A., Bezwada, D., Greco, F., Zandbergen, M., Shen, T., Chiang, C.-Y., Tasdemir, M., Fahrmann, J. F., Grapov, D., Frano, M. R. L., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00879-8 · Cited by 72
Kocher, B. A., & Piwnica-Worms, D. R. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0503 · Cited by 69
Role of Hypoxia in the Evolution and Development of the Cardiovascular System
Fisher, S. A., & Burggren, W. W. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1704 · Cited by 62
“In these mice, the readily measurable luciferase serves as a reporter for O 2 gradients (84).”
Hu, Z., Anandappa, A. J., Sun, J., Kim, J., Leet, D. E., Bozym, D. J., Chen, C., Williams, L., Shukla, S. A., Zhang, W., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843763 · Cited by 57
Simeonova, I., & Huillard, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1675-3 · Cited by 64
“An example is the Rosa26 ODD-Luciferase mouse that can be used to monitor tissue hypoxia in vivo [116].”
BackgroundTao, W., Davide, J. P., Cai, M., Zhang, G.-J., South, V. J., Matter, A., Ng, B., Zhang, Y., & Sepp-Lorenzino, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.147 · Cited by 56
Metadata
- Authors
- Safran, M., Kim, W. Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J. W., DePinho, R. A., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Medical Oncology, Dana–Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; FibroGen, Inc., South San Francisco, CA 94080; and Howard Hughes Medical Institute, Chevy Chase, MD 20815
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-22
- Volume
- 103
- Issue
- 1
- Pages
- 105-110
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1324998
- OpenAlex
- W1992933063
- Cited by
- 305
- References
- 35
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 9 · 2022: 13 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 21 · 2013: 15 · 2012: 17
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- FibroGen
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- hypoxia-inducible factor, HIF prolyl hydroxylase, HIF prolyl hydroxylase inhibitors, tissue hypoxia, bioluminescence reporter, firefly luciferase, oxygen-dependent degradation, hypoxia-inducible factor alpha, erythropoietin, oral bioavailability, non-invasive imaging, mouse model, liver, kidney, gene expression profiling
- MeSH terms
- Animals, Cells, Cultured, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Erythropoietin, Luciferases, Plasmids, Proteins, Molecular Probe Techniques, Cell Hypoxia, DNA Primers, DNA, Complementary, RNA, Untranslated, Models, Animal, Dioxygenases, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor-Proline Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.